ARIX

Arix Bioscience: 32% IRR since inception in 2016

Arix Bioscience plc (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Arix Bioscience: Artios attracts Merck KGaA in deal up to $7bn

Arix Bioscience plc (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Arix Bioscience: Hitting the jackpot

Arix Bioscience plc (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Arix Bioscience Analyst Q&A: Investment team very focused and motivated (LON:ARIX)

Arix Bioscience plc (LON:ARIX)is the topic of conversation when Hardman and Co’s Analyst Martin Hall caught up with DirectorsTalk for an exclusive interview. Q1: Can you tell us what Arix..

Arix Bioscience a diversified portfolio and an IRR of 20% since inception (Analyst Interview)

Arix Bioscience plc (LON:ARIX) is the topic of conversation when Dr Martin Hall, Analyst at Hardman & Co joins DirectorsTalk. Martin explains how Arix differs from other investment vehicles, how..

Arix Bioscience: Realising the valuation disconnect

Arix Bioscience plc (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Arix Bioscience 1Q’20 portfolio update

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Arix Bioscience Resetting the stage

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Arix Bioscience Fiscal 2019 – moving with the times

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Arix Bioscience Analyst Q&A with Dr Dorothea Hill (LON:ARIX)

Arix Bioscience plc (LON:ARIX) is the topic of conversation when Hardman and Co’s Analyst Dr Dorothea Hill caught up with DirectorsTalk for an exclusive interview. Q1: You recently initiated on..

Arix Bioscience: Multiple inflection points in 2020 (Interview)

Arix Bioscience plc (LON:ARIX) is the topic of conversation when Dr Dorothea Hill, Analyst at Hardman & Co joins DirectorsTalk. Having recently initiated on Arix Bioscience Dorothea explains the key..

Arix Bioscience With high risk can come high reward

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Search

Funds

ARIX

Search

Funds

ARIX

FTSE 100

Funds